Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...

Large-cap public M&A is a hard business to break into, but Paul Hastings feels its build, along with the arrival of Schiele, ...

CERo Therapeutics (CERO) presented preclinical results of lead compound CER-1236 in ovarian cancer during the 2025 SITC Spring Scientific ...

Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy ...

Carmell announced a comprehensive corporate rebranding initiative aimed at better aligning the Company’s market and investor facing image with ...

AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics, which spun out of Pfizer ...

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...

After hours: March 12 at 6:45:07 PM EDT Loading Chart for ATOS ...

After hours: March 12 at 7:46:03 PM EDT ...